We specialize in research in the field of health economics and health outcomes assessment (Health Economic & Outcomes Research, HEOR), including health technology assessment (HTA).
Our approach combines real-world data analytics, economic modeling, and treatment effectiveness analysis to create an evidence base necessary for strategic decision-making.

We support pharmaceutical manufacturers, healthcare providers, government agencies, and insurance structures in assessing the cost, effectiveness, and appropriateness of medical interventions. This enables the justification of including technologies in national registries, reimbursement programs, and public procurement, as well as optimizing resource use in the healthcare system.

Our experts have extensive experience in building pharmacoeconomic models, analyzing disease burden, conducting retrospective studies, and preparing HTA dossiers in line with international and national requirements.

Our expertise includes: